drugset / Trial / NCT00535275

NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy

NCT00535275 ↗

Phase 3 Terminated 88 enrolled French Cooperative Thoracic Intergroup
RandomizedSingle-groupOpen-labelTreatment

Summary

Relapses after perioperative chemotherapy and surgery

Timeline

Start
2007-09
Primary completion
2014-11
Completion
2014-11

Outcome

Outcome not reported

Stopped: “Final analysis done, follow-up of patients no more necessary”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 5 unknown —
Subject Cisplatin Other / unclassified 75 mg/m2 —
Background Docetaxel Small molecule 75 mg/m2 —